Moderate coding emphasis
DevOps interviews focus more on scripting and automation than complex algorithms. Expect Python/Bash scripting, data parsing, and basic data structures.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for infrastructure and automation roles.. Explore key insights and preparation tips to help you excel in your interview process.
DevOps interviews focus more on scripting and automation than complex algorithms. Expect Python/Bash scripting, data parsing, and basic data structures.
Design scalable deployment pipelines, monitoring systems, and cloud architectures. Heavy emphasis on reliability and automation.
CI/CD
Pipeline Architecture
Monitoring
Observability Systems
Cloud
Infrastructure as Code
Different companies emphasize different aspects of DevOps expertise and tooling preferences.
Netflix
Chaos engineering and microservices reliability
Stripe
Payment infrastructure and security compliance
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers housing costs approximately 65% lower than San Francisco, with median home prices around $200K versus $1.4M in the Bay Area. Your DevOps salary stretches significantly further, enabling homeownership and substantial savings while maintaining proximity to DC's tech corridor.
Baltimore's DevOps market is less saturated than major tech hubs, offering better positioning opportunities as the city's cybersecurity and fintech sectors expand rapidly.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States